Interesting Image

Polyostotic Fibrous Dysplasia in a Six-year-Old Boy

10.4274/mirt.galenos.2023.79095

• Nevena Manevska
• Dushica Todorova-Stefanovski
• Smiljana Bundovska Kocev
• Sinisha Stojanoski
• Tanja Makazlieva

Received Date: 08.09.2022 Accepted Date: 22.01.2023 Mol Imaging Radionucl Ther 2023;32(2):186-190 PMID: 37337879

• Abstract
• Full Text
• Video - Image
• References
• 7
• 457

Fibrous dysplasia (FD) is a rare congenital benign bone disease that manifests as a defect in the bone remodeling process, affecting the function, differentiation, and maturation of osteoblasts. This process is located in the bone marrow, where the normal marrow tissue is replaced with immature bone islands and fibrous stroma. The etiology is unclear so far, but it is known to be connected with a point mutation of the gene that encodes Gs α protein at the time of embryogenesis, and because of that, all of the affected somatic cells become dysplastic. It is important to determine whether the mutation occurred earlier in the process of embryogenesis so that there will be more mutant cells and the disease will appear in a more severe form. The clinical presentation of FD is variable, so there are plenty of potential differential diagnoses. The most common include Paget disease, non-ossifying fibroma, osteofibrous dysplasia, aneurysmal bone cyst, adamantinoma, giant cell tumor, fracture callus, and low-grade central osteosarcoma.

Keywords: Fibrous dysplasia, bone scan, SPECT

Ethics

Informed Consent: Written informed consent was obtained.

Peer-review: Externally peer-reviewed.

Authorship Contributions

Concept: N.M., Design: N.M., S.B.K., Data Collection or Processing: N.M., S.B.K., Analysis or interpretation:S.S., T.M., Literature Search: D.T-T., T.M., Writing: D.T-T., S.S., N.M.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

Images

1. Jeyaraj P. Histological Diversity, Diagnostic Challenges, and Surgical Treatment Strategies of Fibrous Dysplasia of Upper and Mid-Thirds of the Craniomaxillofacial Complex. Ann Maxillofac Surg 2019;9:289-314.
2. DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 2005;87:1848-1864.
3. https://radiopaedia.org/articles/fibrous-dysplasia
4. Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, Arundel P, Shaw N, Pos VD, Underhil A, Portero D, Heral L, Heegaard AM, Masi L, Monsell F, Stanton R, Dijkstra PDS, Brandi ML, Chapurlat R, Hamdy NAT, Collins MT. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 2019;14:139.
5. Kushchayeva YS, Kushchayev SV, Glushko TY, Tella SH, Teytelboym OM, Collins MT, Boyce AM. Fibrous dysplasia for radiologists: beyond ground glass bone matrix. Insights imaging. Insights Imaging 2018;9:1035-1056.
6. Kinnunen AR, Sironen R, Sipola P. Magnetic resonance imaging characteristics in patients with histopathologically proven fibrous dysplasia-a systematic review. Skeletal Radiol 2020;49:837-845.
7. Zhang L, He Q, Li W, Zhang R. The value of 99mTc-methylene diphosphonate single photon emission computed tomography/computed tomography in diagnosis of fibrous dysplasia. BMC Med Imaging 2017;17:46.
8. Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res 2006;21(Suppl 2):114-119.